WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Breast Cancer Endpoints - Master Primary v2, Tumor assessment provides_evidence_for Disease recurrence, Adjuvant setting endpoints has_component Disease free survival (DFS), Date of progression has_component Tumor assessment, Concepts (e.g. CRF:pCR:Surgical margins are denoted by solid round-edged rectangle, FDA Criteria for Efficacy endpoints for Breast Cancer treatment has_tumor_information Tumor information, Curative intent has_option Neoadjuvant setting endpoints, Therapeutic Efficacy Point has Observation or Assessment, Date of progression has_component Tumor assessment, Disease free survival (DFS) ends_concurrent_with Date of progression, Therapeutic Efficacy Point has Therapeutic/Surgical intervention, Progression free survival (PFS) ends_concurrent_with Death of any cause, Disease free survival (DFS) starts_concurrent_with Date of surgery, Cancer stage has_component M, Hormone receptor status has_component PR status, Date of surgery has_component Tumor assessment, Curative intent has_option Adjuvant setting endpoints, FDA Criteria for Efficacy endpoints for Breast Cancer treatment has_medical_history_information Demographics/Medical history, Cancer stage has_component T, Tumor assessment is_derived_from RECIST v1.1 criteria, Disease free survival (DFS) ends_concurrent_with Death of any cause